Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion. - Wikidata - wikimedia - TriplyDB

Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

http://www.wikidata.org/entity/Q37404353

about

Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study Mechanistic systems modeling to guide drug discovery and development Effects of 6-month sitagliptin treatment on glucose and lipid metabolism, blood pressure, body weight and renal function in type 2 diabetic patients: a chart-based analysis.A model qualification method for mechanistic physiological QSP models to support model-informed drug development.A review of gliptins in 2011.Cardiovascular effects of gliptins.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes.Response: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9).

P2860

Q28084489-26EE99B2-7817-448B-979F-4B65AF0EC165 Q30414988-2D7AA3B1-55C1-45A6-8F74-75EF3FBEE586 Q36132211-61E03BE1-86DD-4EDE-BC3A-8C54173874BD Q36600060-8DA472FE-E69D-4A1E-B8B9-8E632A9D12CF Q37965612-89B72B8C-A99B-4292-AB75-8AA1F956CE16 Q38072259-1A97A152-7765-4657-A8DE-504E599017A1 Q38113092-6D115028-6CBB-4A60-A34F-9958348E2DC1 Q38558336-C4A64FCD-9681-4903-97A9-2BB548786C84 Q42872676-A710F49E-FE6B-4BB8-92B5-AF38054E3B04

P2860

Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

http://www.wikidata.org/entity/Q37404353

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment with sitagliptin or ...... in urinary glucose excretion.

@en

Treatment with sitagliptin or ...... in urinary glucose excretion.

@nl

type

label

Treatment with sitagliptin or ...... in urinary glucose excretion.

@en

Treatment with sitagliptin or ...... in urinary glucose excretion.

@nl

prefLabel

Treatment with sitagliptin or ...... in urinary glucose excretion.

@en

Treatment with sitagliptin or ...... in urinary glucose excretion.

@nl

P1433

Q37404353-5272F99C-F0AA-4496-98EB-CB5C2818C381

P1476

Q37404353-0C866589-B723-45D6-A08E-CF2288402308

P2093

Q37404353-01AD229B-C99A-4C06-971F-2E35C1F81684

Q37404353-40E6D9F4-8815-420A-9280-0410161B0DFE

Q37404353-9BC35DBA-8953-4C81-92B2-A975EF17D3CB

Q37404353-D0C0B382-3A12-4AA1-978A-352AF9DC2F77

P2860

Q37404353-17360A04-5C4A-453D-A21D-68E0A2E3A106

Q37404353-19DE3568-C387-45DB-8E82-12C299C79D95

Q37404353-1EA9C9A8-CF59-44A9-A216-873827FBF1C0

Q37404353-2458A107-258A-406B-BF6D-DE0B87A357A1

Q37404353-29BD33A2-A9B8-47A8-AEA1-6A7828A37042

Q37404353-35287DF0-9E5C-4112-939B-30B4778D5BF4

Q37404353-4144C37C-13D8-4EF1-99A1-F8A009C2B07C

Q37404353-4469231D-02C1-4240-9D7D-56606581992B

Q37404353-570EB1B5-8C61-458F-A198-DC2735E0BC74

Q37404353-604272EF-812F-4829-8EF4-1AF69E3A51AD

P304

Q37404353-44AC5F02-22BA-4FD9-ACE4-F6DCED347E97

P31

Q37404353-C61219AA-ED5B-4BE9-84CD-9B65F17BCC2D

P356

Q37404353-AEE43BE3-C9CD-428C-8D07-6B3CB8F7C532

P433

Q37404353-47698F9F-AF33-4495-BD7A-32337713FE2B

P478

Q37404353-670823FA-B08A-4CCF-9781-679BF0D78749

P577

Q37404353-EC3C8A1B-9B65-4C59-87D3-DACB66CD2823

P5875

Q37404353-5FBE770A-AEA7-4FA8-ACE8-307E307C0727

P698

Q37404353-AB788AF2-0C23-473D-A2B3-9705A427754E

P921

Q37404353-FBF4076B-4FB8-418A-AA02-EEEE00E1286A

Q37404353-b6e5a2b5-55fe-4009-ad28-2253bc81410f

P932

Q37404353-6199A9F8-140B-411B-B3C2-A0ECB4764399

P356

193229680900300108

P1433

Journal of Diabetes Science and Technology

P1476

Treatment with sitagliptin or ...... in urinary glucose excretion.

@en

P2093

Brian G Topp

http://www.w3.org/2001/XMLSchema#string

Charles M Alexander

http://www.w3.org/2001/XMLSchema#string

Scott Q Siler

http://www.w3.org/2001/XMLSchema#string

Steven B Waters

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

Effect of thiazolidinediones on body weight in patients with diabetes mellitus.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans.

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

The obesity epidemic: pathophysiology and consequences of obesity.

Weight gain during insulin therapy in patients with type 2 diabetes mellitus.

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

P304

68-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/193229680900300108

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40834705

http://www.w3.org/2001/XMLSchema#string

P698

20046651

http://www.w3.org/2001/XMLSchema#string

P921

P932

2769847

http://www.w3.org/2001/XMLSchema#string